| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $3,885,361 ) |
| | 2026 | 2026 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | R01DE031382 | Oral commensal fungi and structural immunity | 000 | 5 | NIH | 5/19/2026 | $511,256 |
| | 2026 | 2026 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | R01DK136888 | Spatiotemporal regulation of human islet organogenesis | 000 | 3 | NIH | 2/26/2026 | $614,380 |
| | 2026 | 2026 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | R21DE035711 | Role of immunomodulators IL-33 and SPRR in oropharyngeal candidiasis | 000 | 1 | NIH | 5/1/2026 | $449,625 |
| | 2026 | 2026 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | R01HL176463 | Pulmonary neuroimmune determinants of immunoglobulin production against pneumonia | 000 | 2 | NIH | 5/19/2026 | $656,958 |
| | 2026 | 2026 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | S10OD040317 | Confocal Microscope - Leica Stellaris | 000 | 1 | NIH | 5/7/2026 | $750,000 |
| | 2026 | 2026 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | R01NS131646 | Defining cerebellar pathophysiology in Ataxia Telangiectasia | 001 | 3 | NIH | 3/3/2026 | $67,959 |
| | 2026 | 2026 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | R01NS131646 | Defining cerebellar pathophysiology in Ataxia Telangiectasia | 000 | 3 | NIH | 1/13/2026 | $611,648 |
| | 2026 | 2026 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | R21AI195389 | Cyclic Antifungal Peptides for Drug-Resistant Invasive Fungal Infections | 000 | 1 | NIH | 6/1/2026 | $211,831 |
| | 2026 | 2025 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | R01HL177106 | Sleep loss and circadian misalignment - mechanisms of Insulin Resistance | 000 | 1 | NIH | 5/15/2026 | $0 |
| | 2026 | 2025 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | R01CA288736 | Deciphering functions of the ATR-METTL3-BRCA1 Axis in genome instability and Tumorigenesis | 000 | 2 | NIH | 6/1/2026 | $0 |
| | 2026 | 2025 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | R01DK132875 | Plant-Focused Nutrition in Patients with Diabetes and Chronic Kidney Disease (PLAFOND Study): A Pilot/Feasibility Study | 000 | 3 | NIH | 3/10/2026 | $0 |
| | 2026 | 2025 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | U01FD008652 | DDT-BMQ-000161 Analytic Validation ofNon-Calcified Plaque Volume (NCPV) for Regulatory Qualification as an Enrichment Biomarkerin Coronary Artery Disease Trials | 000 | 1 | FDA | 3/26/2026 | $0 |
| | 2026 | 2025 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | R01HL155104 | Type I IFN signaling during lung development in Down Syndrome | 000 | 3 | NIH | 4/2/2026 | $0 |
| | 2026 | 2025 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | R01AI063503 | Novel Toxins and Receptors in Mucormycosis Pathogenesis and Treatment | 000 | 19 | NIH | 6/3/2026 | $0 |
| | 2026 | 2025 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | R61HD114186 | IND-enabling studies to develop triptonide into the first nonhormonal male pill | 001 | 2 | NIH | 2/10/2026 | $0 |
| | 2026 | 2025 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | R21AI178352 | Delineating host response to central venous catheter associated Candida albicans biofilm infections, and development of novel therapeutics to combat drug resistant biofilms | 000 | 2 | NIH | 6/2/2026 | $0 |
| | 2026 | 2024 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | R01HD099924 | Epitranscriptomic regulation of spermatogenesis and male fertility | 000 | 5 | NIH | 11/21/2025 | $0 |
| | 2026 | 2024 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | R24OD037736 | BRC Modernization of Sterilizing Equipment | 000 | 1 | NIH | 12/12/2025 | -$542 |
| | 2026 | 2023 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | R01AI141202 | Cross-Kingdom Vaccine Targeting Healthcare-Associated Priority Pathogens | 000 | 5 | NIH | 5/20/2026 | -$6,365 |
| | 2026 | 2023 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | R01NS121150 | BRAIN (Biomimetic Regenerative Angiogenic Immunomodulating Nanocomposite) materials for brain repair after stroke | 000 | 2 | NIH | 11/17/2025 | $463,782 |
| | 2026 | 2023 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | R01HL151769 | E-Cigarette Vaping during Pregnancy and Lactation, Germ Cell Epigenetic Memory, and Transgenerational Asthma | 000 | 4 | NIH | 12/4/2025 | -$268,901 |
| | 2026 | 2023 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | R01HD099813 | Maternal Obesity Programs Offspring Hypothalamic Neurogenesis and Appetite: Mechanisms and Prevention of Hyperphagia-mediated Childhood Obesity | 001 | 4 | NIH | 12/29/2025 | -$35,994 |
| | 2026 | 2023 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | R01HD099813 | Maternal Obesity Programs Offspring Hypothalamic Neurogenesis and Appetite: Mechanisms and Prevention of Hyperphagia-mediated Childhood Obesity | 000 | 4 | NIH | 11/24/2025 | -$139,325 |
| | 2026 | 2023 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | R21MH126359 | Behavioral and brain network effects of dysfunction in the cognitive cerebellum | 000 | 2 | NIH | 11/28/2025 | -$99 |
| | 2026 | 2023 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | R01HD100529 | Mechanism of Long Non-coding RNAs Action in leiomyoma | 000 | 4 | NIH | 1/7/2026 | $0 |
| | 2026 | 2023 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | R01AI141202 | Cross-Kingdom Vaccine Targeting Healthcare-Associated Priority Pathogens | 000 | 5 | NIH | 5/20/2026 | -$459 |
| | 2026 | 2022 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | U01AI116400 | Short and long term outcomes of doxycycline versus TMP-SMX for SSTI treatment | 000 | 5 | NIH | 2/19/2026 | -$392 |
|
| Issue Date FY: 2025 ( Subtotal = $13,835,663 ) (Continued on the next page) |
| | 2025 | 2025 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | R01CA288736 | Deciphering functions of the ATR-METTL3-BRCA1 Axis in genome instability and Tumorigenesis | 001 | 2 | NIH | 5/29/2025 | $46,002 |
| | 2025 | 2025 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | R01HD109286 | Tryptophan metabolism and its role in fibroid pathogenesis | 000 | 4 | NIH | 6/4/2025 | $385,250 |
| | 2025 | 2025 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | R01HL166850 | Novel cardiopulmonary exercise testing variables to differentiate neuromuscular deconditioning from disease | 000 | 3 | NIH | 9/8/2025 | $785,006 |
| | 2025 | 2025 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | U01FD008652 | DDT-BMQ-000161 Analytic Validation ofNon-Calcified Plaque Volume (NCPV) for Regulatory Qualification as an Enrichment Biomarkerin Coronary Artery Disease Trials | 000 | 1 | FDA | 9/10/2025 | $249,580 |
| | 2025 | 2025 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | R01DE031382 | Oral commensal fungi and structural immunity | 000 | 4 | NIH | 5/30/2025 | $507,596 |
| | 2025 | 2025 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | R01HL155104 | Type I IFN signaling during lung development in Down Syndrome | 002 | 3 | NIH | 8/27/2025 | $558,694 |
| | 2025 | 2025 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | R21AI187999 | Mouse model of neonatal fungal colonization to study homeostasis and disease | 000 | 1 | NIH | 7/14/2025 | $245,250 |
| | 2025 | 2025 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | R01AI063503 | Novel Toxins and Receptors in Mucormycosis Pathogenesis and Treatment | 000 | 19 | NIH | 7/15/2025 | $554,760 |
| | 2025 | 2025 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | R01NS131646 | Defining cerebellar pathophysiology in Ataxia Telangiectasia | 001 | 2 | NIH | 8/8/2025 | $63,851 |
| | 2025 | 2025 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502-2006 | LOS ANGELES | USA | R01NS131646 | Defining cerebellar pathophysiology in Ataxia Telangiectasia | 000 | 2 | NIH | 1/22/2025 | $574,684 |
| | 2025 | 2025 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | R61HD114186 | IND-enabling studies to develop triptonide into the first nonhormonal male pill | 001 | 2 | NIH | 4/16/2025 | $35,344 |
| | 2025 | 2025 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502-2006 | LOS ANGELES | USA | R61HD114186 | IND-enabling studies to develop triptonide into the first nonhormonal male pill | 000 | 2 | NIH | 1/13/2025 | $318,099 |
| | 2025 | 2025 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | R61HD114186 | IND-enabling studies to develop triptonide into the first nonhormonal male pill | 002 | 2 | NIH | 9/1/2025 | -$318,099 |
| | 2025 | 2025 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502-2006 | LOS ANGELES | USA | R21AI178352 | Delineating host response to central venous catheter associated Candida albicans biofilm infections, and development of novel therapeutics to combat drug resistant biofilms | 000 | 2 | NIH | 2/28/2025 | $198,554 |
| | 2025 | 2025 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | R01AI162802 | Transcriptional networks governing A. fumigatus virulence | 000 | 5 | NIH | 7/22/2025 | $657,546 |
| | 2025 | 2025 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | R01DK136888 | Spatiotemporal regulation of human islet organogenesis | 001 | 2 | NIH | 6/12/2025 | $60,174 |
| | 2025 | 2025 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502-2006 | LOS ANGELES | USA | R01DK136888 | Spatiotemporal regulation of human islet organogenesis | 000 | 2 | NIH | 2/28/2025 | $541,560 |
| | 2025 | 2025 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | P01AI186818 | Deciphering Immunopathogenesis of MUCORmycosis to ADVANCE Risk stratification, Diagnosis and Management of the Disease | 001 | 1 | NIH | 9/3/2025 | -$2,205,213 |
| | 2025 | 2025 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | R01HL177106 | Sleep loss and circadian misalignment - mechanisms of Insulin Resistance | 000 | 1 | NIH | 8/4/2025 | $743,388 |
| | 2025 | 2025 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | P01AI186818 | Deciphering Immunopathogenesis of MUCORmycosis to ADVANCE Risk stratification, Diagnosis and Management of the Disease | 000 | 1 | NIH | 7/1/2025 | $2,205,213 |
| | 2025 | 2025 | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 1124 W CARSON ST BLDG MRL | TORRANCE | CA | 90502 | LOS ANGELES | USA | P01AI186818 | Deciphering Immunopathogenesis of MUCORmycosis to ADVANCE Risk stratification, Diagnosis and Management of the Disease | 001 | 1 | NIH | 9/3/2025 | $2,205,213 |
|
